| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/29/2007 | CN101027073A Natriuretic compounds, conjugates, and uses thereof |
| 08/29/2007 | CN101024831A A tumor necrosis factor related ligand |
| 08/29/2007 | CN101024673A Novel sea fungus polysaccharide YCP single clone body, its preparing method and use |
| 08/29/2007 | CN100334110C Sperm protein monoclonal antibody and its preparing method and use |
| 08/28/2007 | US7262306 Chemiluminescent compounds and their use |
| 08/28/2007 | US7262289 KCNQ potassium channels and methods of modulating same |
| 08/28/2007 | US7262278 Anti-HLA-DR antibody |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262276 Two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv |
| 08/28/2007 | US7262275 Graft polymer of polyester and polypeptide; prevent cyclization |
| 08/28/2007 | US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 08/28/2007 | US7262271 Immunogens as well as antibodies |
| 08/28/2007 | US7262267 Polypeptide mediating cell permeability |
| 08/28/2007 | US7262167 Treating tumors and other conditions in a patient is provided. The method involves administering to the patient a treatment medicament. The medicament contains a first component and a second component. The first component can be a quantity of |
| 08/28/2007 | US7262062 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262028 Recombinant production of mixtures of antibodies |
| 08/28/2007 | US7261901 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 08/28/2007 | US7261895 Peptide tag for monitoring and purification of proteins |
| 08/28/2007 | US7261894 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof |
| 08/28/2007 | US7261893 Neutralizing antibodies against GDF-8 and uses therefor |
| 08/28/2007 | US7261891 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 08/28/2007 | CA2124460C Production of anti-self antibodies from segment repertoires and displayed on phage |
| 08/28/2007 | CA2123355C Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007094668A1 Affinity regions |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007093663A1 Method for obtaining anti-hdc antibodies and applications of same |
| 08/23/2007 | WO2007093657A2 Method for the molecular diagnosis of prostate cancer and kit for implementing same |
| 08/23/2007 | WO2007093630A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007093008A1 Antibodies to insulin-like growth factor i receptor |
| 08/23/2007 | WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies |
| 08/23/2007 | WO2007068411A3 Therapeutic vaccine |
| 08/23/2007 | WO2007067597A3 Methods and compositions for needleless delivery of binding partners |
| 08/23/2007 | WO2007059136A3 Rankl antibody-pth/pthrp chimeric molecules |
| 08/23/2007 | WO2007044695A3 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 08/23/2007 | WO2007001677A9 Compositions and methods for immunomodulation in an organism |
| 08/23/2007 | WO2006126068A3 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia |
| 08/23/2007 | WO2006117699A3 Transgenic animals and methods of making recombinant antibodies |
| 08/23/2007 | WO2006116369A3 Method for treating dementia or alzheimer's disease with a cd20 antibody |
| 08/23/2007 | WO2006113139A3 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 08/23/2007 | WO2006088494A3 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 08/23/2007 | WO2006081473A8 Methods for diagnosis and prognosis of epithelial cancers |
| 08/23/2007 | WO2006067122A3 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 08/23/2007 | WO2006041680A3 Method for treating vasculitis |
| 08/23/2007 | WO2004087738A3 Lupus antibodies for passive immunotherapy of hiv/aids |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | WO2000024869A3 Methods for modulating cell fusion |
| 08/23/2007 | US20070199080 Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders |
| 08/23/2007 | US20070199079 Monitoring APP cleavage in transgenic rodents comprising an APP swedish mutation |
| 08/23/2007 | US20070199078 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 08/23/2007 | US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070197639 Using ichthyin allelic expression profile to screen/diagnose/prognose syndromic autosomal recessive congenital ichthyosis (ARCI) |
| 08/23/2007 | US20070197443 Methods and Compositions for Modulating Immunity |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070196931 selectively kill Fusobacterium varium cells, or neutralize the toxin produced by Fusobacterium varium cells; differential diagnosis between ulcerative colitis and inflammatory bowel disease |
| 08/23/2007 | US20070196916 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 08/23/2007 | US20070196874 Method of examining colon cancer and colon adenoma |
| 08/23/2007 | US20070196867 GPCR expressing cell lines and antibodies |
| 08/23/2007 | US20070196860 Methods for Measuring Real Time Kinase Activity |
| 08/23/2007 | US20070196858 Separation Matrix And Method Of Purification |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196390 Equine herpesvirus vaccine |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196376 Binding proteins specific for insulin-like growth factors and uses thereof |
| 08/23/2007 | US20070196374 Immunoglobulins which binding to endothelial growth factor for therapy for cell proliferative disorders; antitumor agents |
| 08/23/2007 | US20070196373 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 08/23/2007 | US20070196371 Soluble il-17rcx4 and methods of using in inflammation |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196366 Methods for treating cancer using an immunotoxin |
| 08/23/2007 | US20070196365 Immunoglobulin heavy chain variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/23/2007 | US20070196363 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/23/2007 | US20070196346 Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer |
| 08/23/2007 | US20070196345 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196276 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 08/23/2007 | US20070196274 Immunoconjugates with improved efficacy for the treatment of diseases |
| 08/23/2007 | CA2822302A1 Methods of impairing osteoclast differentiation |
| 08/23/2007 | CA2785046A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2642828A1 Affinity regions |
| 08/23/2007 | CA2642606A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/23/2007 | CA2638915A1 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2631327A1 Her2 binding polypeptides and uses thereof |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820860A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820855A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 08/22/2007 | EP1820806A1 Affinity regions |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820513A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/22/2007 | EP1819829A1 Recombinant method for making multimeric proteins |